Incorrect username and/or password, please try again or click to reset.

Class 2 Medicines Recall: Nitrofurantoin CNX Therapeutics 100 mg Prolonged-Release capsules, EL(25)A/05

2025-02-05 10:00:55 (1 month(s) ago)

Summary

CNX Therapeutics is recalling the batches listed in this notification as a precautionary measure due to a small number of packs that contain an additional tablet of Nitrofurantoin. The registered product is a capsule contain…

Read full MHRA article

Respond to this alert